
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (14): 1709-1715.DOI: 10.12114/j.issn.1007-9572.2022.0750
Special Issue: 心血管最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2022-08-12
Revised:2022-11-19
Published:2023-05-15
Online:2022-12-02
Contact:
ZHONG Qiuan
通讯作者:
钟秋安
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0750
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | 民族〔n(%)〕 | 受教育程度〔n(%)〕 | SBP(mm Hg) | DBP(mm Hg) | 吸烟〔n(%)〕 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 汉族 | 其他 | 初中及以下 | 高中及以上 | 从不吸烟 | 曾经吸烟 | 当前吸烟 | ||||||
| CIMT正常组 | 693 | 202/491 | 56.0±10.2 | 451(65.1) | 242(34.9) | 616(88.9) | 77(11.1) | 137±20 | 79±13 | 547(78.9) | 63(9.1) | 83(12.0) |
| CIMT增厚组 | 45 | 22/23 | 63.5±7.6 | 20(44.4) | 25(55.6) | 41(91.1) | 4(8.9) | 159±24 | 83±15 | 27(60.0) | 7(15.6) | 11(24.4) |
| 检验统计量值 | 7.789a | 4.847 | 7.793a | 0.213a | 7.231 | 2.147 | 8.965a | |||||
| P值 | 0.005 | <0.001 | 0.005 | 0.644 | <0.001 | 0.032 | 0.011 | |||||
| 组别 | 饮酒〔n(%)〕 | 颈总动脉内径(mm) | BMI(kg/m2) | LDL-C(mmol/L) | HDL-C(mmol/L) | TG〔M(P25,P75),mmol/L〕 | TC(xmmol/L) | ACR〔M(P25,P75),mg/g〕 | eGFR〔ml·min-1·(1.73 m2)-1〕 | |||
| 从不饮酒 | 曾经饮酒 | 当前饮酒 | ||||||||||
| CIMT正常组 | 349(50.4) | 95(13.7) | 249(35.9) | 6.5±0.8 | 23.6±3.2 | 3.0±0.9 | 1.6±0.4 | 1.6(1.1,2.2) | 5.4±1.0 | 7.6(3.9,15.1) | 88.8±16.3 | |
| CIMT增厚组 | 20(44.4) | 4(8.9) | 21(46.7) | 7.4±0.8 | 22.8±3.3 | 3.0±0.8 | 1.6±0.5 | 1.6(1.0,2.1) | 5.8±1.0 | 13.8(9.0,39.3) | 85.4±12.9 | |
| 检验统计量值 | 2.358a | 7.152 | 1.635 | 0.196 | 0.403 | 0.402b | 3.095 | 5.157b | 1.376 | |||
| P值 | 0.307 | <0.001 | 0.102 | 0.844 | 0.686 | 0.687 | 0.002 | <0.001 | 0.169 | |||
| 组别 | LPA〔M(P25,P75),mg/L〕 | ICAM-1〔M(P25,P75),μg/L〕 | VCAM-1〔M(P25,P75),μg/L〕 | ApoA/ApoB | CRP〔M(P25,P75),mg/L〕 | ALB〔M(P25,P75),mg/L〕 | GLU(mmol/L) | 糖尿病〔n(%)〕 | ALT〔M(P25,P75),U/L〕 | AST〔M(P25,P75),U/L〕 | PHYMET〔M(P25,P75),MET-min/w〕 | |
| CIMT正常组 | 135.0(64.8,282.7) | 78.1(52.8,127.0) | 225.2(170.2,299.7) | 1.7±0.6 | 0.9(0.4,1.9) | 9.1(4.7,19.3) | 5.8±1.5 | 61(8.8) | 11.8(8.9,17.0) | 24.0(20.9,29.0) | 5 593(3 564,8 319) | |
| CIMT增厚组 | 229.0(117.0,284.0) | 78.1(50.4,150.5) | 298.0(216.0,352.3) | 1.5±0.7 | 1.5(0.9,2.6) | 16.1(10.5,46.0) | 6.1±1.7 | 6(13.3) | 12.0(9.8,18.0) | 26.0(22.9,33.1) | 7 479(3 885,13 146) | |
| 检验统计量值 | 2.461b | 0.200b | 3.341b | 1.704 | 3.213b | 4.014b | 1.183 | 1.051a | 0.807b | 1.676b | 2.451b | |
| P值 | 0.013 | 0.841 | <0.001 | 0.044 | <0.001 | <0.001 | 0.237 | 0.305 | 0.420 | 0.094 | 0.014 | |
Table 1 Comparison of general data and cervical color ultrasound results between the two groups
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | 民族〔n(%)〕 | 受教育程度〔n(%)〕 | SBP(mm Hg) | DBP(mm Hg) | 吸烟〔n(%)〕 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 汉族 | 其他 | 初中及以下 | 高中及以上 | 从不吸烟 | 曾经吸烟 | 当前吸烟 | ||||||
| CIMT正常组 | 693 | 202/491 | 56.0±10.2 | 451(65.1) | 242(34.9) | 616(88.9) | 77(11.1) | 137±20 | 79±13 | 547(78.9) | 63(9.1) | 83(12.0) |
| CIMT增厚组 | 45 | 22/23 | 63.5±7.6 | 20(44.4) | 25(55.6) | 41(91.1) | 4(8.9) | 159±24 | 83±15 | 27(60.0) | 7(15.6) | 11(24.4) |
| 检验统计量值 | 7.789a | 4.847 | 7.793a | 0.213a | 7.231 | 2.147 | 8.965a | |||||
| P值 | 0.005 | <0.001 | 0.005 | 0.644 | <0.001 | 0.032 | 0.011 | |||||
| 组别 | 饮酒〔n(%)〕 | 颈总动脉内径(mm) | BMI(kg/m2) | LDL-C(mmol/L) | HDL-C(mmol/L) | TG〔M(P25,P75),mmol/L〕 | TC(xmmol/L) | ACR〔M(P25,P75),mg/g〕 | eGFR〔ml·min-1·(1.73 m2)-1〕 | |||
| 从不饮酒 | 曾经饮酒 | 当前饮酒 | ||||||||||
| CIMT正常组 | 349(50.4) | 95(13.7) | 249(35.9) | 6.5±0.8 | 23.6±3.2 | 3.0±0.9 | 1.6±0.4 | 1.6(1.1,2.2) | 5.4±1.0 | 7.6(3.9,15.1) | 88.8±16.3 | |
| CIMT增厚组 | 20(44.4) | 4(8.9) | 21(46.7) | 7.4±0.8 | 22.8±3.3 | 3.0±0.8 | 1.6±0.5 | 1.6(1.0,2.1) | 5.8±1.0 | 13.8(9.0,39.3) | 85.4±12.9 | |
| 检验统计量值 | 2.358a | 7.152 | 1.635 | 0.196 | 0.403 | 0.402b | 3.095 | 5.157b | 1.376 | |||
| P值 | 0.307 | <0.001 | 0.102 | 0.844 | 0.686 | 0.687 | 0.002 | <0.001 | 0.169 | |||
| 组别 | LPA〔M(P25,P75),mg/L〕 | ICAM-1〔M(P25,P75),μg/L〕 | VCAM-1〔M(P25,P75),μg/L〕 | ApoA/ApoB | CRP〔M(P25,P75),mg/L〕 | ALB〔M(P25,P75),mg/L〕 | GLU(mmol/L) | 糖尿病〔n(%)〕 | ALT〔M(P25,P75),U/L〕 | AST〔M(P25,P75),U/L〕 | PHYMET〔M(P25,P75),MET-min/w〕 | |
| CIMT正常组 | 135.0(64.8,282.7) | 78.1(52.8,127.0) | 225.2(170.2,299.7) | 1.7±0.6 | 0.9(0.4,1.9) | 9.1(4.7,19.3) | 5.8±1.5 | 61(8.8) | 11.8(8.9,17.0) | 24.0(20.9,29.0) | 5 593(3 564,8 319) | |
| CIMT增厚组 | 229.0(117.0,284.0) | 78.1(50.4,150.5) | 298.0(216.0,352.3) | 1.5±0.7 | 1.5(0.9,2.6) | 16.1(10.5,46.0) | 6.1±1.7 | 6(13.3) | 12.0(9.8,18.0) | 26.0(22.9,33.1) | 7 479(3 885,13 146) | |
| 检验统计量值 | 2.461b | 0.200b | 3.341b | 1.704 | 3.213b | 4.014b | 1.183 | 1.051a | 0.807b | 1.676b | 2.451b | |
| P值 | 0.013 | 0.841 | <0.001 | 0.044 | <0.001 | <0.001 | 0.237 | 0.305 | 0.420 | 0.094 | 0.014 | |
| 变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| SBPa | 0.031 | 0.009 | 11.864 | 0.001 | 1.032(1.013,1.050) |
| TCb | 0.444 | 0.202 | 4.831 | 0.028 | 1.558(1.049,2.315) |
| PHYMET | 0.800 | 0.279 | 8.222 | 0.004 | 2.226(1.289,3.844) |
| CRP | 0.380 | 0.172 | 4.881 | 0.027 | 1.462(1.043,2.050) |
| 超重肥胖 | -0.731 | 0.404 | 3.274 | 0.070 | 0.481(0.218,1.063) |
| ACR | 0.279 | 0.147 | 3.602 | 0.057 | 1.321(0.991,1.761) |
| LPA | 0.345 | 0.207 | 2.778 | 0.095 | 1.412(0.941,2.118) |
| VCAM-1 | 0.743 | 0.481 | 2.386 | 0.122 | 2.102(0.819,5.393) |
| 肾功能 | -0.685 | 0.416 | 2.711 | 0.100 | 0.504(0.223,1.139) |
| ApoA/ApoB | -0.634 | 0.351 | 3.263 | 0.071 | 0.531(0.267,1.055) |
Table 2 Multivariate Logistic regression analysis of influencing factors of the thickening of carotid intima-media thickness
| 变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| SBPa | 0.031 | 0.009 | 11.864 | 0.001 | 1.032(1.013,1.050) |
| TCb | 0.444 | 0.202 | 4.831 | 0.028 | 1.558(1.049,2.315) |
| PHYMET | 0.800 | 0.279 | 8.222 | 0.004 | 2.226(1.289,3.844) |
| CRP | 0.380 | 0.172 | 4.881 | 0.027 | 1.462(1.043,2.050) |
| 超重肥胖 | -0.731 | 0.404 | 3.274 | 0.070 | 0.481(0.218,1.063) |
| ACR | 0.279 | 0.147 | 3.602 | 0.057 | 1.321(0.991,1.761) |
| LPA | 0.345 | 0.207 | 2.778 | 0.095 | 1.412(0.941,2.118) |
| VCAM-1 | 0.743 | 0.481 | 2.386 | 0.122 | 2.102(0.819,5.393) |
| 肾功能 | -0.685 | 0.416 | 2.711 | 0.100 | 0.504(0.223,1.139) |
| ApoA/ApoB | -0.634 | 0.351 | 3.263 | 0.071 | 0.531(0.267,1.055) |
| 变量 | β(95%CI) | SE值 | t值 | P值 |
|---|---|---|---|---|
| SBPa | 0.017(0.009,0.025) | 0.004 | 4.166 | <0.001 |
| TCb | 0.020(0.003,0.038) | 0.009 | 2.308 | 0.021 |
| PHYMET | 0.022(0.002,0.041) | 0.010 | 2.119 | 0.034 |
| 吸烟情况 | ||||
| 曾经吸烟 | 0.047(-0.022,0.117) | 0.036 | 1.136 | 0.182 |
| 当前吸烟 | 0.076(0.011,0.141) | 0.033 | 2.305 | 0.021 |
| CRP | 0.010(-0.003,0.023) | 0.007 | 1.462 | 0.144 |
| ACR | 0.013(-0.001,0.023) | 0.007 | 1.771 | 0.077 |
| LPA | 0.007(-0.007,0.021) | 0.007 | 1.015 | 0.311 |
| ApoA/ApoB | -0.017(-0.043,0.008) | 0.013 | 1.337 | 0.182 |
| 饮酒情况 | ||||
| 曾经饮酒 | 0.028(-0.018,0.074) | 0.023 | 1.199 | 0.231 |
| 当前饮酒 | 0.020(-0.017,0.057) | 0.019 | 1.072 | 0.284 |
| GLU | 0.057(-0.025,0.139) | 0.042 | 1.357 | 0.175 |
| 糖尿病一级家族史 | 0.042(-0.018,0.102) | 0.031 | 1.380 | 0.168 |
Table 3 Multiple linear regression analysis of the factors influencing carotid intima-media thickness
| 变量 | β(95%CI) | SE值 | t值 | P值 |
|---|---|---|---|---|
| SBPa | 0.017(0.009,0.025) | 0.004 | 4.166 | <0.001 |
| TCb | 0.020(0.003,0.038) | 0.009 | 2.308 | 0.021 |
| PHYMET | 0.022(0.002,0.041) | 0.010 | 2.119 | 0.034 |
| 吸烟情况 | ||||
| 曾经吸烟 | 0.047(-0.022,0.117) | 0.036 | 1.136 | 0.182 |
| 当前吸烟 | 0.076(0.011,0.141) | 0.033 | 2.305 | 0.021 |
| CRP | 0.010(-0.003,0.023) | 0.007 | 1.462 | 0.144 |
| ACR | 0.013(-0.001,0.023) | 0.007 | 1.771 | 0.077 |
| LPA | 0.007(-0.007,0.021) | 0.007 | 1.015 | 0.311 |
| ApoA/ApoB | -0.017(-0.043,0.008) | 0.013 | 1.337 | 0.182 |
| 饮酒情况 | ||||
| 曾经饮酒 | 0.028(-0.018,0.074) | 0.023 | 1.199 | 0.231 |
| 当前饮酒 | 0.020(-0.017,0.057) | 0.019 | 1.072 | 0.284 |
| GLU | 0.057(-0.025,0.139) | 0.042 | 1.357 | 0.175 |
| 糖尿病一级家族史 | 0.042(-0.018,0.102) | 0.031 | 1.380 | 0.168 |
| [1] |
胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220. DOI:10.3969/j.issn.1000-3614.2019.03.001.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
樊萌语,吕筠,何平平.国际体力活动问卷中体力活动水平的计算方法[J].中华流行病学杂志,2014,35(8):961-964. DOI:10.3760/cma.j.issn.0254-6450.2014.08.019.
|
| [8] |
国家卫生健康委员会脑卒中防治专家委员会血管超声专业委员会,中国超声医学工程学会浅表器官及外周血管超声专业委员会,中国超声医学工程学会颅脑及颈部血管超声专业委员会.头颈部血管超声若干问题的专家共识(颈动脉部分)[J].中国脑血管病杂志,2020,17(6):346-353. DOI:10.3969/j.issn.1672-5921.2020.06.013.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
金文胜,潘长玉.国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华内分泌代谢杂志,2005,21(4):412-413. DOI:10.3760/j.issn:1000-6699.2005.04.054.
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
翁根龙,徐怡芬,陆建林.社区老年颈动脉粥样硬化患者的综合干预效果评价[J].现代预防医学,2018,45(10):1787-1792.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [1] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [2] | DONG Yongfei, CHEN Zhaoyan, SUN Peiyuan, HUANG Huang, HU Zhuolun, LIU Zhencen, CHEN Haichang, LI Xuechao, TIAN Yunhe, LI Zijun, LIU Yadan, LEI Xinyi, ZHANG Wei, YAN Tianming, ZHOU Congjun, WU Fengyi, LILI Shiluo, ZHANG Guanqun, YAN Qi, WU Mengyao, FU Ruiying, LIN Yubing, MA Xiuqi, ZHU Cairong, ZHANG Yawei. Development and Validation of a Core Knowledge Questionnaire for Primary Cancer Prevention: a Delphi and Web-based Respondent-driven Sampling Study [J]. Chinese General Practice, 2026, 29(28): 4147-4156. |
| [3] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [4] | ZHANG Xuechao, QI Qi, WU Xinyu, HAN Quanle, LI Lei, DENG Jie, LI Cangtuo, YUE Bocheng, WU Shouling, LI Kangbo. Association between the Atherogenic Index of Plasma and New-onset Chronic Kidney Disease [J]. Chinese General Practice, 2026, 29(24): 3440-3446. |
| [5] | WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin. Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(22): 3154-3161. |
| [6] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [7] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [8] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [9] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [10] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [11] | LIU Daiyue, LIU Xincan, LAN Zhenzhen. Research Progress on Postprandial Hyperlipidemia and Its Therapeutic Approaches [J]. Chinese General Practice, 2026, 29(18): 2546-2553. |
| [12] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [13] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [14] | SUN Qinyu, DENG Yifan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Clinical Study of HbA1c/ApoA-1, TyG-BMI and Their Combination to Predict the Severity of Coronary Artery Calcification [J]. Chinese General Practice, 2026, 29(09): 1137-1145. |
| [15] | LEI Yingying, ZHENG Siying, WANG Wenxin, JIANG Hong. Prevalence Trend and Prediction of Hypertensive Heart Disease in the World and China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(05): 641-648. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||